ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,800.13
-0.14%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
152.843
-0.14%
Brent Oil
83.105
0.41%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Adamis Pharmaceuticals Corporation (ADMP)

  7. Adamis Pharmaceuticals Corporation (ADMP) ニュース

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ADMP
日付受信時刻ニュースソース見出しコード企業名
2023/09/0905 : 50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/09/0801 : 00GlobeNewswire Inc.Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/09/0205 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/3005 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/2206 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/2122 : 15GlobeNewswire Inc.Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/1505 : 38Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/1105 : 03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/0502 : 43GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of $8.0 Million Public OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/0405 : 59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/0405 : 55Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/0221 : 30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/0213 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/08/0106 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/07/2906 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/07/2905 : 58Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/07/2821 : 30GlobeNewswire Inc.Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid ExpertNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/07/2719 : 08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/07/2710 : 17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/07/2505 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/07/2505 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/07/1405 : 37Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/06/2620 : 30GlobeNewswire Inc.Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use DisorderNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/06/2220 : 30GlobeNewswire Inc.Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose PreventionNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/06/1619 : 01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/06/1304 : 22Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/05/3107 : 14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/05/2705 : 29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/05/2605 : 26GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
2023/05/2305 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP

最近閲覧した銘柄

USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
AMEX
XLF
Financial Select Sector
NASDAQ
NVDA
NVIDIA
NYSE
CVX
Chevron
NYSE
AXP
American Express
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AAPL
Apple
NYSE
BAC
Bank of America
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有